Company / Working Capital
NextCure, Inc. Working Capital History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$221.2M
FY2021
5-year range
$221.2M / $325.0M
FY2019-FY2021
Trend
-20.3%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $325M to $221M over the past 2 years.
Based on SEC 10-K filings.
$221M in FY2021.
Declined from $325M to $221M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, working capital decreased 20.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $221.2M | -20.3% |
| FY2020 | $277.7M | -14.6% |
| FY2019 | $325.0M | - |
As of FY2021 · SEC 10-K Annual Filings · Updated Jun 28, 2026